PharmacoEconomics

Cost-Effectiveness Analysis: Developing Nations Left Behind
pp. 359-361(3)
Author: Singer, Mendel E.

Perspectives on Patient-Reported Outcomes: Content Validity and Qualitative Research in a Changing Clinical Trial Environment
pp. 363-370(8)
Authors: Nancy Kline Leidy,; Vernon, Margaret

Economic Evaluation of Interventions to Treat Opiate Dependence: A Review of the Evidence
pp. 371-393(23)
Author: Doran, Christopher M.

Economic Evaluations in Rheumatoid Arthritis: A Critical Review of Measures Used to Define Health States
pp. 395-408(14)
Authors: Bansback, Nick; Ara, Roberta; Karnon, Jonathan; Anis, Aslam

Methodological Issues in Evaluating Cost Effectiveness of Adjuvant Aromatase Inhibitors in Early Breast Cancer: A Need for Improved Modelling to Aid Decision Making
pp. 409-423(15)
Author: Annemans, Lieven

A Multicentre, Prospective Study to Evaluate Costs of Septic Patients in Brazilian Intensive Care Units
pp. 425-434(10)
Authors: Sogayar, Ana M.C.; Machado, Flavia R.; Rea-Neto, Alvaro; Dornas, Amselmo; Grion, Cintia M.C.; Lobo, Suzana M.A.; Tura, Bernardo R.; Silva, Carla L.O.; Cal, Ruy G.R.; Beer, Idal; Vilto Michels Jr,; Jorge Safi Jr,; Kayath, Marcia; Silva, Eliezer

Updated Estimates of Survival and Cost Effectiveness for Imatinib versus Interferon-α Plus Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukaemia
pp. 435-446(12)
Authors: Reed, Shelby D.; Anstrom, Kevin J.; Li, Yanhong; Schulman, Kevin A.